Tenax Therapeutics (TENX) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.72% |
| Dec 31, 2025 | 1.82% |
| Sep 30, 2025 | 5.78% |
| Jun 30, 2025 | 5.37% |
| Mar 31, 2025 | -17.50% |
| Dec 31, 2024 | 3.52% |
| Sep 30, 2024 | -947.64% |
| Jun 30, 2024 | 25.22% |
| Mar 31, 2024 | -28.16% |
| Dec 31, 2023 | 12.11% |
| Sep 30, 2023 | 16.82% |
| Jun 30, 2023 | 7.08% |
| Mar 31, 2023 | -578.66% |
| Dec 31, 2022 | 44.20% |
| Sep 30, 2022 | 47.35% |
| Jun 30, 2022 | -149.28% |
| Mar 31, 2022 | 48.07% |
| Dec 31, 2021 | 33.16% |
| Sep 30, 2021 | -282.80% |
| Jun 30, 2021 | 45.87% |
| Mar 31, 2021 | 39.94% |
| Dec 31, 2020 | 22.91% |
| Sep 30, 2020 | -91.24% |
| Jun 30, 2020 | 6.25% |
| Mar 31, 2020 | 10.05% |
| Dec 31, 2019 | 24.24% |
| Sep 30, 2019 | 20.00% |
| Jun 30, 2019 | 17.69% |
| Mar 31, 2019 | 15.85% |
| Dec 31, 2018 | -164.85% |
| Sep 30, 2018 | 24.20% |
| Jun 30, 2018 | 3.18% |
| Mar 31, 2018 | 14.36% |
| Dec 31, 2017 | 9.46% |
| Sep 30, 2017 | 2.98% |
| Jun 30, 2017 | 29.76% |
| Mar 31, 2017 | 5.70% |
| Dec 31, 2016 | -77.59% |
| Sep 30, 2016 | 24.86% |
| Jun 30, 2016 | -205.04% |
| Mar 31, 2016 | 83.84% |
| Dec 31, 2015 | -547.82% |
| Sep 30, 2015 | 53.40% |
| Apr 30, 2013 | 5.46% |
| Jan 31, 2013 | 45.17% |
| Oct 31, 2012 | 43.83% |
| Jul 31, 2012 | -43.15% |
| Apr 30, 2012 | 42.71% |
| Jan 31, 2012 | -63.73% |
| Oct 31, 2011 | 49.87% |
| Jul 31, 2011 | -320.00% |
| Apr 30, 2011 | -82.25% |
| Jan 31, 2011 | 37.61% |
| Oct 31, 2010 | 69.35% |